{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T18:57:20Z","timestamp":1776365840129,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Dr. Junghanns GmbH, Aschersleben, Germany"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.phymed.2012.08.003","type":"journal-article","created":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T01:22:41Z","timestamp":1346462561000},"page":"1216-1222","source":"Crossref","is-referenced-by-count":33,"title":["Valerian extract characterized by high valerenic acid and low acetoxy valerenic acid contents demonstrates anxiolytic activity"],"prefix":"10.1016","volume":"19","author":[{"given":"F.","family":"Felgentreff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Brattstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2012.08.003_bib0005","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1517\/13543784.14.5.601","article-title":"The benzodiazepine binding site of GABAA receptors as a target for the development of novel anxiolytics","volume":"14","author":"Atack","year":"2005","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.phymed.2012.08.003_bib0010","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.2174\/156802611795371350","article-title":"GABAA receptor subtype-selective modulators. I. \u03b12\/\u03b13\u2014selective agonist as non-sedating anxiolytics","volume":"11","author":"Atack","year":"2011","journal-title":"Current Topics Medicinal Chemistry"},{"key":"10.1016\/j.phymed.2012.08.003_bib0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1124\/jpet.109.158303","article-title":"Reducing abuse liability of GABAA\/benzodiazepine ligands via selective partial agonist efficacy at \u03b11 and \u03b12\/3 subtypes","volume":"332","author":"Ator","year":"2010","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/j.phymed.2012.08.003_bib0140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuropharm.2008.06.013","article-title":"GABAA receptors as in vivo substrate fort he anxiolytic action of valerenic acid, a major constituent of valerian root extracts","volume":"56","author":"Benke","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phymed.2012.08.003_bib0020","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.amjmed.2006.02.026","article-title":"Valerian for sleep: a systematic review and meta-analysis","volume":"119","author":"Bent","year":"2006","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.phymed.2012.08.003_bib0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10354-007-0442-6","article-title":"Scientific evidence for a fixed extract combination (Ze 91019) from valerian and hops traditionally used as a sleep-inducing aid","volume":"157","author":"Brattstr\u00f6m","year":"2007","journal-title":"Wiener Medizinische Wochenschrift"},{"key":"10.1016\/j.phymed.2012.08.003_bib0030","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00439-002-0766-7","article-title":"Functional characterization of the new human GABA(A) receptor mutation bet3 (R192H)","volume":"111","author":"Buhr","year":"2002","journal-title":"Human Genetics"},{"key":"10.1016\/j.phymed.2012.08.003_bib0035","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: a review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.phymed.2012.08.003_bib0040","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.2174\/092986707782023190","article-title":"GABAA\/Bz receptor subtypes as target for selective drugs","volume":"14","author":"Da Settino","year":"2007","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.phymed.2012.08.003_bib0045","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1124\/mol.105.015982","article-title":"The comparative models of GABAA receptor extracellular and transmembrane domains: important insights in pharmacology and function","volume":"68","author":"Ernst","year":"2005","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.phymed.2012.08.003_bib0050","first-page":"271","article-title":"Die pharmakologische Wertbestimmung des Baldrians","volume":"7","author":"Haffner","year":"1929","journal-title":"Munchener Medizinische Wochenschrift"},{"key":"10.1016\/j.phymed.2012.08.003_bib0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.phymed.2007.11.027","article-title":"Extracts of Valeriana officinalis L. s.I. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties","volume":"15","author":"Hattesohl","year":"2008","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2012.08.003_bib0060","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.2174\/1381612054021024","article-title":"GABAA receptor channel pharmacology","volume":"11","author":"Johnston","year":"2005","journal-title":"Current Pharmaceutical Design"},{"issue":"1","key":"10.1016\/j.phymed.2012.08.003_bib0145","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuropharm.2007.04.018","article-title":"Valerenic acid potentiates and inhibits GABAA receptors: molecular mechanism and subunit specificity","volume":"53","author":"Khom","year":"2007","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.phymed.2012.08.003_bib0150","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1476-5381.2010.00865.x","article-title":"Valerenic acid derivatives as novel subunit-selective ligands \u2013 in vitro and in vivo characterization","volume":"161","author":"Khom","year":"2010","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.phymed.2012.08.003_bib0065","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1055\/s-2008-1074491","article-title":"HPLC-based activity profiling approach for the discovery of GABAA receptor ligands using an automated two electrode voltage clamp assay on Xenopus oocytes","volume":"74","author":"Kim","year":"2008","journal-title":"Planta Medica"},{"key":"10.1016\/j.phymed.2012.08.003_bib0070","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1097\/00001756-200112210-00056","article-title":"Deletion of the GABA(A) receptor beta 3 subunit eliminates the hypnotic actions of oleamide in mice","volume":"12","author":"Laposky","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.phymed.2012.08.003_bib0075","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00441-006-0284-3","article-title":"GABA(A) receptor diversity and pharmacology","volume":"326","author":"M\u00f6hler","year":"2006","journal-title":"Cell and Tissue Research"},{"key":"10.1016\/j.phymed.2012.08.003_bib0080","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.phymed.2009.10.020","article-title":"Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats","volume":"17","author":"Murphy","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2012.08.003_bib0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/jaoac\/89.1.8","article-title":"Chemical fingerprinting of valerian species: simultaneous determination of valerenic acids, flavonoids, and phenylpropanoids using liquid chromatography with ultraviolet detection","volume":"89","author":"Navarrete","year":"2006","journal-title":"Journal of AOAC International"},{"issue":"3","key":"10.1016\/j.phymed.2012.08.003_bib0090","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1124\/pr.108.00505","article-title":"Internationale Union of Pharmacology. LXX. Subtypes of \u03b3-aminobutyric acid A receptors: classification on the basis of subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacological Review"},{"key":"10.1016\/j.phymed.2012.08.003_bib0100","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1523\/JNEUROSCI.5012-10.2011","article-title":"The GABAA receptor \u03b1+\u03b2-interface: a novel target for subtype selective drugs","volume":"31","author":"Ramerstorfer","year":"2011","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.phymed.2012.08.003_bib0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00008877-199711000-00003","article-title":"Animal models of anxiety: where next?","volume":"8","author":"Rodgers","year":"1997","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.phymed.2012.08.003_bib0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/15622970600868525","article-title":"GABAA receptors as targets for novel anxiolytic drugs","volume":"7","author":"Rupprecht","year":"2006","journal-title":"The World Journal of Biological Psychiatry"},{"key":"10.1016\/j.phymed.2012.08.003_bib0115","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/ptr.2197","article-title":"Modulation of postsynaptic potentials in rat cortical neurons by valerian extracts macerated with different alcohols: involvement of adenosines A1- and GABAA receptors","volume":"21","author":"Sichardt","year":"2007","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.phymed.2012.08.003_bib0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0031-6997(25)06840-1","article-title":"Structure and pharmacology of \u03b3-aminobutyric acid A receptor subtypes","volume":"47","author":"Sieghart","year":"1995","journal-title":"Pharmacological Review"},{"key":"10.1016\/j.phymed.2012.08.003_bib0125","article-title":"A novel GABAA receptor pharmacology: drugs interacting with the \u03b1+\u03b2-interface","author":"Sieghart","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.phymed.2012.08.003_bib0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phymed.2012.08.003_bib0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-2007-993761","article-title":"Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid","volume":"74","author":"Trauner","year":"2008","journal-title":"Planta Medica"},{"issue":"2","key":"10.1016\/j.phymed.2012.08.003_bib0155","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1213\/01.ANE.0000096189.70405.A5","article-title":"The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity","volume":"98","author":"Yuan","year":"2004","journal-title":"Anesthesia & Analgesia"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711312002528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711312002528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T16:41:23Z","timestamp":1744044083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711312002528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":30,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0944711312002528"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2012.08.003","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}